Evidence map›Paper›PMID 30733460›Full record

ArticleScientific reports2019

The influence of four pharmaceuticals on Chlorellapyrenoidosa culture.

Yonggang Zhang, Jun Guo, Tianming Yao, Yalei Zhang, Xuefei Zhou, Huaqiang Chu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. The Potential ofInternational journal of environmental research and public health · 2021
    Article
  7. Article
  8. Article
  9. Review
  10. Transcriptional Analysis ofInternational journal of environmental research and public health · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yonggang ZhangSchool of Chemical Science and Engineering, Tongji University, Shanghai, 200092, China.
Jun GuoState Key Laboratory of Pollution Control and Resource Reuse, Tongji University, Shanghai, 200092, China.
Tianming YaoSchool of Chemical Science and Engineering, Tongji University, Shanghai, 200092, China. tmyao@tongji.edu.cn.
Yalei ZhangState Key Laboratory of Pollution Control and Resource Reuse, Tongji University, Shanghai, 200092, China. zhangyalei@tongji.edu.cn.
Xuefei ZhouState Key Laboratory of Pollution Control and Resource Reuse, Tongji University, Shanghai, 200092, China.
Huaqiang ChuState Key Laboratory of Pollution Control and Resource Reuse, Tongji University, Shanghai, 200092, China.
Tongji University · CNState Key Laboratory of Pollution Control and Resource Reuse · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There has been a developing technology in algae with pharmaceuticals wastewater. However, the effect and the underlying mechanism of pharmaceuticals on algae are not well understood. To investigate the effect and mechanism of pharmaceuticalson microalgae, four pharmaceuticals of clofibric acid (CLF), ciprofloxacin (CIP), diclofenac (DCF) and carbamazepine (CBZ) on C. pyrenoidosa culture were analyzed. At low concentrations (<10 mg/L), the pharmaceuticals, especially the DCF, exhibited positive effects on both the structure and function of algal cultures; algal growth (i.e., chlorophyll a accumulation, lipid accumulation) and activities of antioxidant enzymes were stimulated. The algal metabolite differences of various DCF concentrations were investigated and a total of 91 substances were identified, whose samples were clustered and clearly separated. The key metabolomics pathway analysis found that the DCF promoted the carbohydrate and fatty acid metabolic pathway in C. pyrenoidosa under relatively low concentrations (<10 mg/L). However, the algae metabolomics pathway was disturbed significantly under the action of a high concentration of DCF (>100 mg/L). The study detected the effects of four pharmaceuticals on C. pyrenoidosa and demonstrated that the usage of metabolomics analysis complemented with DCF could be an effective approach to understand the mechanism of molecular evolution in C. pyrenoidosa for microalgal biomass and bioenergy from wastewater in researches of biological resources.

Indexed as

Pharmaceutical PreparationsCarbamazepineCatalaseCell Culture TechniquesChlorellaChlorophyll ACiprofloxacinClofibric AcidDiclofenacDose-Response Relationship, DrugLipid MetabolismMetabolomicsMicroalgaeParticle SizeSuperoxide DismutaseCarbamazepineCatalaseChlorophyll ACiprofloxacinClofibric AcidDiclofenacPharmaceutical PreparationsSuperoxide Dismutase

Identifiers

PMID30733460
PMCPMC6367373
OpenAlexW2924629034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.